This inventor holds 4 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976-1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JA (1976 - 1977)
- Ibaraki, JA (1977)
Company Filing History:
Years Active: 1976-1977
Title: Koji Nishijima: Innovator in Antimicrobial Research
Introduction
Koji Nishijima is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of antimicrobial research, particularly through his innovative work in penicillin derivatives. With a total of 4 patents to his name, Nishijima's inventions have the potential to impact medical treatments significantly.
Latest Patents
Nishijima's latest patents include novel penicillins known as .alpha.-Alkylsulfobenzyl penicillins. These compounds are characterized by a branched chain alkyl group containing from 3 to 14 carbon atoms. They are designed to be easily absorbed in the blood and tissues through oral administration, demonstrating excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria. Notably, they are particularly effective against microorganisms of the genus Pseudomonas, such as Pseudomonas aeruginosa. Another significant patent is for d-.alpha.-Isobutylsulfobenzylpenicillin hemi-solvate crystals. These crystals exhibit excellent antibacterial activities and improved stability regarding shelf-life, making them a valuable addition to antimicrobial therapies.
Career Highlights
Koji Nishijima is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on developing innovative solutions to combat bacterial infections. Nishijima's research has been instrumental in advancing the understanding of penicillin derivatives and their applications in medicine.
Collaborations
Nishijima has collaborated with notable colleagues, including Hiroshi Akimoto and Tadashi Hanaoka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of antimicrobial research.
Conclusion
Koji Nishijima's contributions to antimicrobial research through his innovative patents highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for new treatments that can effectively combat bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile